Clinical Trials List
Protocol NumberMK-8591A-054
Active
2023-01-17 - 2030-01-31
Phase III
Recruiting1
ICD-10B20
Human immunodeficiency virus [HIV] disease
ICD-9042
Human immunodeficiency virus（HIV）infection disease
-
Trial Applicant
Merck Sharp & Dohme (I.A.) LLC
-
Sponsor
-
Trial scale
Multi-Regional Multi-Center
-
Update
2026/03/01
Investigators and Locations
Co-Principal Investigator
- 蔡宏津 Division of Infectious Disease
The Actual Total Number of Participants Enrolled
0 Recruiting
Condition/Disease
Objectives
Test Drug
Active Ingredient
Dosage Form
Dosage
Endpoints
Inclution Criteria
The Estimated Number of Participants
-
Taiwan
3 participants
-
Global
650 participants
